| Dr Chi M Pham, MD | |
|
500 S Henderson St Ste 200, Fort Worth, TX 76104-2154 | |
| (174) 131-5008 | |
| (817) 413-1499 |
| Full Name | Dr Chi M Pham |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 23 Years |
| Location | 500 S Henderson St Ste 200, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881710226 | NPI | - | NPPES |
| 196293802 | Medicaid | TX | |
| 8AQ007 | Other | TX | BCBSTX |
| P00662593 | Other | TX | RAILROAD MEDICARE |
| 163293801 | Medicaid | TX | |
| 196293803 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Harris Methodist Hospital Fort Worth | Fort worth, TX | Hospital |
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Texas Health Harris Methodist Hospital Southwest F | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Beginning in 2015, Springer will publish a new online-only journal called ChemTexts -The Textbook Journal of Chemistry.
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations, according to a new study presented at the 2014 American Thoracic Society International Conference.
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.
Medtronic, Inc. today announced the start of the Engager European Pivotal Trial to pursue CE Mark for the Engager Transcatheter Aortic Valve Implantation System in patients suffering from severe aortic stenosis.
› Verified 3 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Beginning in 2015, Springer will publish a new online-only journal called ChemTexts -The Textbook Journal of Chemistry.
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations, according to a new study presented at the 2014 American Thoracic Society International Conference.
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.
Medtronic, Inc. today announced the start of the Engager European Pivotal Trial to pursue CE Mark for the Engager Transcatheter Aortic Valve Implantation System in patients suffering from severe aortic stenosis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chi M Pham, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Dr Chi M Pham, MD 500 S Henderson St Ste 200, Fort Worth, TX 76104-2154 Ph: (174) 131-5008 |
News Archive
Beginning in 2015, Springer will publish a new online-only journal called ChemTexts -The Textbook Journal of Chemistry.
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations, according to a new study presented at the 2014 American Thoracic Society International Conference.
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.
Medtronic, Inc. today announced the start of the Engager European Pivotal Trial to pursue CE Mark for the Engager Transcatheter Aortic Valve Implantation System in patients suffering from severe aortic stenosis.
› Verified 3 days ago
Charles A Carlton, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1622 8th Avenue, Suite 110, Fort Worth, TX 76104 Phone: 817-926-2561 Fax: 817-921-3708 | |
Paul J Garcia, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5701 Bryant Irvin Rd, Suite 302, Fort Worth, TX 76132 Phone: 817-294-9000 Fax: 817-294-9010 | |
Stevan A Gonzalez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1250 8th Ave, Suite 515, Fort Worth, TX 76104 Phone: 817-922-4675 Fax: 817-922-4645 | |
Jeremy Aaron Ross, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 W Magnolia Ave, Fort Worth, TX 76104 Phone: 817-759-7000 Fax: 817-759-7027 | |
Elie B Choufani, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 601 W Terrell Ave, Fort Worth, TX 76104 Phone: 817-852-8305 | |
Syed Hadi Jafri, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1300 W Terrell Ave Fl 2, Fort Worth, TX 76104 Phone: 817-820-4906 Fax: 817-820-4815 | |
Cheryl K Mcdonald, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1125 College Ave, Fort Worth, TX 76104 Phone: 817-810-9810 Fax: 817-810-9815 |